Tag Archives: OMER

Omeros Corp (OMER) Receives a Buy from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $32. The company’s shares opened today at $14.01. McCarthy observed: “Omeros reported 3Q18 with $4.6M in Omidria

Tuesday’s Midday Movers: Tokai Pharma (TKAI), Titan Pharmaceuticals (TTNP), Amarin (AMRN), Dynavax (DVAX), Omeros Corp (OMER)

So far Tuesday, October 23, NASDAQ is up 1.95% and the S&P is up 1.35%. Here are this morning’s most active stocks: Tokai Pharma (NASDAQ:TKAI), Titan Pharmaceuticals (NASDAQ:TTNP), Amarin (NASDAQ:AMRN), Dynavax (NASDAQ:DVAX) and Omeros Corp (NASDAQ:OMER). Tokai Pharma is down

Omeros Corp (OMER) Gets a Buy Rating from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on Omeros Corp (NASDAQ: OMER) today and set a price target of $32. The company’s shares opened today at $24.54, close to its 52-week high of $27. McCarthy commented: “As expected,

H.C. Wainwright Believes Omeros Corp (NASDAQ: OMER) Still Has Room to Grow

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Omeros Corp (NASDAQ: OMER) today and set a price target of $34. The company’s shares closed yesterday at $23.35, close to its 52-week high of $25.20. Selvaraju wrote: “Valuation methodology,

Maxim Group Believes Omeros Corp (NASDAQ: OMER) Won’t Stop Here

Maxim Group analyst Jason McCarthy maintained a Buy rating on Omeros Corp (NASDAQ: OMER) today and set a price target of $32. The company’s shares opened today at $22.75, close to its 52-week high of $25.20. McCarthy commented: “Omeros announced

Wedbush Sticks to Their Hold Rating for Omeros Corp (OMER)

Wedbush analyst Liana Moussatos reiterated a Hold rating on Omeros Corp (NASDAQ: OMER) today and set a price target of $20. The company’s shares opened today at $22.28. According to TipRanks.com, Moussatos is a 3-star analyst with an average return